These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9630370)

  • 21. Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile.
    Darkoh C; Odo C; DuPont HL
    mBio; 2016 Aug; 7(4):. PubMed ID: 27531912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
    Lamont JT
    Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxin and enterotoxin production by Clostridium difficile.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
    Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile recurrent infection: possible implication of TA systems.
    Gil F; Pizarro-Guajardo M; Álvarez R; Garavaglia M; Paredes-Sabja D
    Future Microbiol; 2015; 10(10):1649-57. PubMed ID: 26439907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between production of toxins A and B and types of Clostridium difficile.
    Wren B; Heard SR; Tabaqchali S
    J Clin Pathol; 1987 Dec; 40(12):1397-401. PubMed ID: 3123524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.
    Zhang Y; Feng H
    Pathog Dis; 2016 Jun; 74(4):ftw024. PubMed ID: 27044305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
    Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
    Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of toxin A negative/B positive Clostridium difficile strains.
    Brazier JS; Stubbs SL; Duerden BI
    J Hosp Infect; 1999 Jul; 42(3):248-9. PubMed ID: 10440000
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clostridium difficile-induced enterocolitis: pathogenesis, clinical course, epidemiology and laboratory diagnosis].
    Meyer-Kawohl R; Bockemühl J
    Immun Infekt; 1986 Apr; 14(2):63-7. PubMed ID: 3519433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type.
    Barbanti F; Spigaglia P
    Anaerobe; 2016 Dec; 42():123-129. PubMed ID: 27725230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins.
    Just I; Hofmann F; Genth H; Gerhard R
    Int J Med Microbiol; 2001 Sep; 291(4):243-50. PubMed ID: 11680784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunisation of mares with binding domains of toxins A and B of Clostridium difficile elicits serum and colostral antibodies that block toxin binding.
    Artiushin S; Timoney JF; Fettinger M; Fallon L; Rathgeber R
    Equine Vet J; 2013 Jul; 45(4):476-80. PubMed ID: 23206274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile colitis: pathogenesis and host defence.
    Abt MC; McKenney PT; Pamer EG
    Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the extent of Clostridium difficile colonisation and toxin accumulation in sows and neonatal piglets.
    Grześkowiak Ł; Zentek J; Vahjen W
    Anaerobe; 2016 Aug; 40():5-9. PubMed ID: 27108595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile infection of the gut.
    Dodson AP; Borriello SP
    J Clin Pathol; 1996 Jul; 49(7):529-32. PubMed ID: 8813947
    [No Abstract]   [Full Text] [Related]  

  • 37. Clostridium difficile--Second International Symposium (ICDS).
    Tillotson G
    IDrugs; 2007 Aug; 10(8):538-42. PubMed ID: 17665327
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhancement of Clostridium difficile toxin production in biotin-limited conditions.
    Yamakawa K; Karasawa T; Ikoma S; Nakamura S
    J Med Microbiol; 1996 Feb; 44(2):111-4. PubMed ID: 8642571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses induced by Clostridium difficile.
    Péchiné S; Collignon A
    Anaerobe; 2016 Oct; 41():68-78. PubMed ID: 27108093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of Clostridium difficile-associated diarrhoea.
    Pothoulakis C
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1041-7. PubMed ID: 8944363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.